๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Esophagus Cancer

The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy. NCT06019455n/a1 site๐Ÿ“ Guangzhou Sun Yat-sen University Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma NCT00288119n/a10 sites๐Ÿ“ Baltimore๐Ÿ“ Rochester๐Ÿ“ St Louis Case Western Reserve University ยท Tests: Balloon Capsule Device, Endoscopy VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites๐Ÿ“ Santa Rosa๐Ÿ“ Hartford๐Ÿ“ Washington D.C. VM Oncology, LLC ยท Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06) NCT06780111Phase 1, Phase 252 sites๐Ÿ“ Pittsburgh๐Ÿ“ Natal๐Ÿ“ Porto Alegre Merck Sharp & Dohme LLC ยท Tests: Pembrolizumab, I-DXd, Leucovorin, Levoleucovorin, 5-Fluorouracil (5-FU) Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer NCT07367516Phase 1, Phase 230 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Fuzhou Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ยท Tests: TQB6411 Injection Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC NCT05738434Phase 21 site๐Ÿ“ Zhengzhou The First Affiliated Hospital of Zhengzhou University ยท Tests: Camrelizumab+Apatinib+Chemotherapyโ†’Camrelizumab+Apatinib, Camrelizumab+Chemotherapyโ†’Camrelizumab A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma NCT06843889Phase 21 site๐Ÿ“ Guangzhou Nanfang Hospital, Southern Medical University ยท Tests: Toripalimab (240mg day1, Q3W*3cycle) Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma NCT06476067n/a2 sites๐Ÿ“ Nagoya๐Ÿ“ Chลซล City of Hope Medical Center ยท Tests: Surgery AB122 Platform Study NCT04999761Phase 19 sites๐Ÿ“ Aichi๐Ÿ“ Chiba๐Ÿ“ Ehime Taiho Pharmaceutical Co., Ltd. ยท Tests: AB122, AB122, TAS-116, TAS-120, TAS-115 Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer NCT06962137Phase 26 sites๐Ÿ“ Antwerp๐Ÿ“ Brussels๐Ÿ“ Brussels Universitaire Ziekenhuizen KU Leuven ยท Tests: zolbetuximab, Retrospective cohort, no intervention Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy NCT06586242Phase 21 site๐Ÿ“ Xi'an Xijing Hospital ยท Tests: Penpulimab;Anlotinib;albumin paclitaxel;oxaliplatin;lobaplatin Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE) NCT06440174n/a14 sites๐Ÿ“ Abercynon๐Ÿ“ Bournemouth๐Ÿ“ Cambridge University Hospital Southampton NHS Foundation Trust ยท Tests: endoscopic ultrasound A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Maintenance After First-Line Chemoimmunotherapy in Advanced ESCC (Esophageal Squamous Cell Carcinoma) NCT07863141Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: anlotinib + PD-1 inhibitor, PD-1 inhibitor Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms NCT06687603NA5 sites๐Ÿ“ Aurora๐Ÿ“ Baltimore๐Ÿ“ Chapel Hill Case Comprehensive Cancer Center ยท Tests: EsoCheck, EsoGuard sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE) NCT05332002Phase 26 sites๐Ÿ“ Hamilton๐Ÿ“ Lakewood๐Ÿ“ Long Branch Rutgers, The State University of New Jersey ยท Tests: Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI) A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors NCT07814248Phase 13 sites๐Ÿ“ Maumee๐Ÿ“ Portland๐Ÿ“ Fairfax TwoStep Therapeutics, Inc. ยท Tests: TS-104 Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites๐Ÿ“ San Francisco๐Ÿ“ Walnut Creek University of California, San Francisco ยท Tests: Radiation Therapy (RT) Endoscopic Submucosal Dissection Registry NCT06033976n/a1 site๐Ÿ“ Bucharest Carol Davila University of Medicine and Pharmacy ยท Tests: Endoscopic submucosal dissection (ESD) Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients NCT05850130NA15 sites๐Ÿ“ Amiens๐Ÿ“ Caen๐Ÿ“ Crรฉteil GERCOR - Multidisciplinary Oncology Cooperative Group ยท Tests: Acupuncture intervention, No acupuncture Comparison of Drainage Methods in Minimally Invasive Esophagectomy (DEMURE๏ผ‰ NCT07004634NA1 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: Chest mediastinal tube, Abdominal mediastinal tube, Chest tube + chest mediastinal tube A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou Chongqing Precision Biotech Co., Ltd ยท Tests: CEA-targeted CAR-T cells Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC NCT07177794Phase 31 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: toripalimab, capecitabine A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR) NCT06232083Phase 11 site๐Ÿ“ Hefei Anhui Provincial Hospital ยท Tests: PLDR+Cardunizumab CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1 NCT04455282n/a2 sites๐Ÿ“ Cologne๐Ÿ“ Mรผnster Heinrich-Heine University, Duesseldorf Chemoradiotherapy for Advanced Esophageal Cancer NCT02297217Phase 21 site๐Ÿ“ Calgary AHS Cancer Control Alberta ยท Tests: Carboplatin and Taxol (paclitaxel), External Beam Radiation Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown Esophagectomy NCT07043491n/a1 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Endoscopy Prehabilitation in High-risk Oncologic Surgery NCT07638410NA1 site๐Ÿ“ Philadelphia Fox Chase Cancer Center ยท Tests: Multidisciplinary Prehabilitation Program Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry NCT00574327n/a1 site๐Ÿ“ Kansas City Midwest Biomedical Research
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy